Scott L. Burrows - Mar 1, 2022 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: Chief Financial Officer
Signature: /s/ Scott L. Burrows
Stock symbol: ARQT
Transactions as of: Mar 1, 2022
Transactions value $: -$7,456
Form type: 4
Date filed: 3/3/2022, 03:17 PM
Previous filing: Jan 4, 2022
Next filing: Mar 7, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARQT	Common Stock	Sale	-$7.46K	-420	-1.85%	$17.75	22.3K	Mar 1, 2022	Direct	F1, F2, F3

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"). Shares and RSUs remain subject to a lock-up agreement with the underwriters for the Issuer's follow-on offering in February 2021.
F2	The transaction was executed in multiple trades in prices ranging from $17.40 to $18.185, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3	Includes 4,800 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.